Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.49 CAD | +6.52% | +2.08% | -30.46% |
05-27 | Cytophage Technologies Ltd. Strengthens Board of Directors | CI |
04-30 | Cuspis Capital III Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Steven Theriault
CEO | Chief Executive Officer | - | 02-07 |
Julius Kalcevich
DFI | Director of Finance/CFO | 49 | 02-07 |
Heather Medwick
COO | Chief Operating Officer | - | 02-07 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Harold Wolkin
CHM | Chairman | 72 | - |
Andrew Hurley
BRD | Director/Board Member | - | - |
Steven Theriault
CEO | Chief Executive Officer | - | 02-07 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 8,444,316 | 8,359,872 ( 99.00 %) | 0 | 99.00 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-30.46% | 15.37M | |
+40.73% | 739B | |
+31.84% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+14.94% | 240B | |
+9.47% | 210B | |
-4.95% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- CYTO Stock
- Company Cytophage Technologies Ltd.